ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,643Medicare Part D Prescriptions Filled, Including Refills

Rank: 151 out of 5176

$1.63M Total Retail Price of All Prescriptions

Rank: 90 out of 5176

352 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 352 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 352 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 16,936 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

58% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

50 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 830 788 1 15
NEXIUM 668 641 2 16
AMLODIPINE BESYLATE 454 454 3 2
METOPROLOL TARTRATE 447 412 4 6
ZOLPIDEM TARTRATE 427 416 5 17
JANUMET 410 385 6 77
METOPROLOL SUCCINATE 409 394 7 11
LIDODERM 385 378 8 59
SYNTHROID 370 349 9 33
PLAVIX 310 300 10 29
DEXILANT 290 285 11 118
COUMADIN 256 256 12 112
CREON 254 254 13 111
SIMVASTATIN 251 247 14 1
HYDROCHLOROTHIAZIDE 245 238 15 10
NAMENDA 220 217 16 47
MECLIZINE HCL 205 205 17 81
ISOSORBIDE MONONITRATE ER 204 204 18 44
BENICAR HCT 198 193 19 110
HYDRALAZINE HCL 194 194 20 73
TAMSULOSIN HCL 188 184 21 20
DIOVAN HCT 182 175 22 39
ALLOPURINOL 175 167 23 41
BENICAR 174 174 24 100
ATENOLOL 159 145 25 12
VOLTAREN 154 137 26 97
CLOPIDOGREL 150 146 27 26
CELEBREX 149 141 28 80
DIOVAN 147 147 29 19
OMEPRAZOLE 147 136 29 3
FUROSEMIDE 143 139 31 8
LIPITOR 142 142 32 51
LOVAZA 140 140 33 43
ZETIA 136 132 34 68
POTASSIUM CHLORIDE 133 122 35 34
GLIMEPIRIDE 123 105 36 37
AMLODIPINE BESYLATE-BENAZEPRIL 122 107 37 55
LOSARTAN-HYDROCHLOROTHIAZIDE 121 109 38 35
SPIRIVA 116 116 39 54
CLOBETASOL PROPIONATE 115 114 40 130
LANSOPRAZOLE 110 107 41 113
SINGULAIR 109 105 42 62
ATORVASTATIN CALCIUM 108 106 43 9
CARVEDILOL 105 95 44 24
JANUVIA 104 104 45 25
ADVAIR DISKUS 99 93 46 32
TOPROL XL 99 99 46 227
BYSTOLIC 97 92 48 96
LOSARTAN POTASSIUM 96 83 49 14
SOLARAZE 95 95 50 157
ENALAPRIL MALEATE 94 88 51 22
AZITHROMYCIN 93 86 52 42
DIGOXIN 91 81 53 56
LEXAPRO 88 88 54 193
VESICARE 87 79 55 210
ONGLYZA 86 86 56 153
ENALAPRIL-HYDROCHLOROTHIAZIDE 83 81 57 212
LYRICA 83 75 57 133
METFORMIN HCL 80 79 59 7
ESCITALOPRAM OXALATE 79 79 60 89
CLONIDINE HCL 77 77 61 79
LUNESTA 76 76 62 242
DONEPEZIL HCL 76 76 62 28
PAROXETINE HCL 74 74 64 93
NASONEX 74 68 64 178
GABAPENTIN 71 68 66 21
MELOXICAM 71 57 66 53
AVODART 70 70 68 107
ULORIC 68 56 69 280
MUPIROCIN 68 64 69 182
NITROSTAT 68 68 69 205
LABETALOL HCL 66 66 72 114
CLOTRIMAZOLE-BETAMETHASONE 65 65 73 94
EXELON 63 63 74 162
MULTAQ 63 63 74 414
GLYBURIDE-METFORMIN HCL 63 63 R 74 76
MOMETASONE FUROATE 62 62 77 251
PRANDIN 61 60 78 150
PRAMIPEXOLE DIHYDROCHLORIDE 60 55 79 339
LIDOCAINE 59 58 80 179
CHLORHEXIDINE GLUCONATE 59 59 80 202
ACETAMINOPHEN-CODEINE 58 56 S3 82 127
COMBIVENT 58 58 82 156
HYDROCODONE BIT-IBUPROFEN 57 52 S3 84 458
ALCOHOL SWABS 57 57 84 115
TRAMADOL HCL 55 55 86 40
KOMBIGLYZE XR 55 48 86 291
ATENOLOL-CHLORTHALIDONE 55 55 86 161
MICARDIS HCT 52 40 89 180
IBUPROFEN 52 48 89 72
FINASTERIDE 51 51 91 69
TRAMADOL HCL-ACETAMINOPHEN 51 51 91 116
GLIPIZIDE 50 50 93 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.